Farallon Capital Management LLC Alkermes Plc. Transaction History
Farallon Capital Management LLC
- $17.4 Billion
- Q1 2025
A detailed history of Farallon Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,389,800 shares of ALKS stock, worth $42.4 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
1,389,800Holding current value
$42.4 Million% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$889 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$556 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$360 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$245 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$210 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.01B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...